职责描述： Support the completion of clinical trials and coordination of various logistical and administrative tasks in accordance with GCP, SOPs and the study protocol.
Roles and Responsibilities： 1. Assist Study Manager and/or Clinical Research Associate in the preparation, handling, distribution, filing, and archiving of essential documents for accuracy and completeness with periodic review according to the scope of work and SOPs； 2. Assist Study Manager with preparation, handling and distribution of Clinical Trial Supplies and maintenance of tracking information； 3. Responsible for tracking site budget related matters, including processing invoices, tracking payments etc. according to the scope of work and SOPs； 4. Responsible for scheduling meetings, taking minutes, updating all trackers, coordinating the translation of essential documents and providing ad-hoc support as appropriate； 5. May perform assigned administrative tasks to support team members with clinical trial execution
任职要求： Educational Qualifications. - Minimum bachelor degree in clinical medicine or pharmacy Relevant Experience: . - Experience in clinical research execution preferred. Language Requirements (if any): - Good oral and written capability of English/Chinese, 5. Capable of working in English working environment
Sinovant Sciences is an innovative biopharmaceutical company based in Shanghai, China with offices in Beijing and Hong Kong. Sinovant was founded by Chinese scientists and physicians, including Chinese “Returnees”, and is backed by CITIC Private Equity, one of China’s leading investment funds, and Roivant Sciences, a leading global family of innovative healthcare companies. Leveraging CITIC Private Equity’s strategic insights into healthcare markets in Greater China and Asia and Roivant’s global business development network and drug development capabilities, Sinovant is uniquely positioned to bring cutting-edge global medical innovation to China, and transformative Chinese medical innovation to the world.
Sinovant has a diverse pipeline of 13 investigational products in development, among which 5 drug candidates are in phase III or beyond. Our products span over 8 therapeutic areas including oncology, infectious disease, urology, metabolic disease, pulmonary disease, gastroenterology, dermatology and rare diseases.
As a young and energetic company, we have gathered a group of ambitious and seasoned Chinese scientists and physicians at home and abroad, outstanding talents in various fields, and young people who aspire to be the leading team in China's pharmaceutical industry.
For more information, please visit: www.sinovant.com